Literature DB >> 34875233

NeuroD1 induces microglial apoptosis and cannot induce microglia-to-neuron cross-lineage reprogramming.

Yanxia Rao1, Siling Du2, Baozhi Yang3, Yuqing Wang3, Yuxin Li4, Ruofan Li5, Tian Zhou6, Xiangjuan Du4, Yang He4, Yafei Wang4, Xin Zhou4, Ti-Fei Yuan7, Ying Mao8, Bo Peng9.   

Abstract

The regenerative capacity of neurons is limited in the central nervous system (CNS), with irreversible neuronal loss upon insult. In contrast, microglia exhibit extraordinary capacity for repopulation. Matsuda et al. (2019) recently reported NeuroD1-induced microglia-to-neuron conversion, aiming to provide an "unlimited" source to regenerate neurons. However, the extent to which NeuroD1 can exert cross-lineage reprogramming of microglia (myeloid lineage) to neurons (neuroectodermal lineage) is unclear. In this study, we unexpectedly found that NeuroD1 cannot convert microglia to neurons in mice. Instead, NeuroD1 expression induces microglial cell death. Moreover, lineage tracing reveals non-specific leakage of similar lentiviruses as previously used for microglia-to-neuron conversion, which confounds the microglia-to-neuron observation. In summary, we demonstrated that NeuroD1 cannot induce microglia-to-neuron cross-lineage reprogramming. We here propose rigid principles for verifying glia-to-neuron conversion. This Matters Arising paper is in response to Matsuda et al. (2019), published in Neuron.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NeuroD1; artifact; cell death; cross-lineage; glia-to-neuron conversion; lineage tracing; microglia; regeneration; reprogramming; viral leakage

Mesh:

Substances:

Year:  2021        PMID: 34875233     DOI: 10.1016/j.neuron.2021.11.008

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  10 in total

Review 1.  Dead Cas(t) light on new life: CRISPRa-mediated reprogramming of somatic cells into neurons.

Authors:  Meiling Zhou; Yu Cao; Ming Sui; Xiji Shu; Feng Wan; Bin Zhang
Journal:  Cell Mol Life Sci       Date:  2022-05-24       Impact factor: 9.261

Review 2.  The Art of Reprogramming for Regenerative Medicine.

Authors:  Junqi Kuang; Tao Huang; Duanqing Pei
Journal:  Front Cell Dev Biol       Date:  2022-06-30

Review 3.  In vivo glia-to-neuron conversion: pitfalls and solutions.

Authors:  Lei-Lei Wang; Chun-Li Zhang
Journal:  Dev Neurobiol       Date:  2022-05-23       Impact factor: 3.102

Review 4.  Astrocyte Reprogramming in Stroke: Opportunities and Challenges.

Authors:  Zhouzhou Peng; Hui Lu; Qingwu Yang; Qi Xie
Journal:  Front Aging Neurosci       Date:  2022-05-19       Impact factor: 5.702

5.  Failure of observing NeuroD1-induced microglia-to-neuron conversion in vitro is not attributed to the low NeuroD1 expression level.

Authors:  Yanxia Rao; Bo Peng
Journal:  Mol Brain       Date:  2022-04-05       Impact factor: 4.041

Review 6.  Hippocampal neurogenesis and pro-neurogenic therapies for Alzheimer's disease.

Authors:  Jie Zheng
Journal:  Animal Model Exp Med       Date:  2022-02-06

7.  A single factor elicits multilineage reprogramming of astrocytes in the adult mouse striatum.

Authors:  Yunjia Zhang; Boxun Li; Sergio Cananzi; Chuanhui Han; Lei-Lei Wang; Yuhua Zou; Yang-Xin Fu; Gary C Hon; Chun-Li Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-07       Impact factor: 12.779

Review 8.  Critical Examination of Müller Glia-Derived in vivo Neurogenesis in the Mouse Retina.

Authors:  Ye Xie; Bo Chen
Journal:  Front Cell Dev Biol       Date:  2022-03-31

Review 9.  Application of Small Molecules in the Central Nervous System Direct Neuronal Reprogramming.

Authors:  Jingyi Wang; Shiling Chen; Chao Pan; Gaigai Li; Zhouping Tang
Journal:  Front Bioeng Biotechnol       Date:  2022-07-07

10.  Ascl1 phospho-site mutations enhance neuronal conversion of adult cortical astrocytes in vivo.

Authors:  Hussein Ghazale; EunJee Park; Lakshmy Vasan; James Mester; Fermisk Saleh; Andrea Trevisiol; Dawn Zinyk; Vorapin Chinchalongporn; Mingzhe Liu; Taylor Fleming; Oleksandr Prokopchuk; Natalia Klenin; Deborah Kurrasch; Maryam Faiz; Bojana Stefanovic; JoAnne McLaurin; Carol Schuurmans
Journal:  Front Neurosci       Date:  2022-08-18       Impact factor: 5.152

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.